Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-020276
Filing Date
2022-05-31
Accepted
2022-05-31 20:17:28
Documents
1
Period of Report
2022-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6201
  Complete submission text file 0000899243-22-020276.txt   7562
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O HOLOGIC, INC. BEDFORD MA 01730
Business Address
MUIR GLENN P (Reporting) CIK: 0001181190 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 22985466